These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15548792)

  • 21. Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?
    Robinson WH; Genovese MC; Moreland LW
    Arthritis Rheum; 2001 Sep; 44(9):1977-83. PubMed ID: 11592357
    [No Abstract]   [Full Text] [Related]  

  • 22. [Inhibitors of tumour necrosis factor-alpha for the treatment of arthritis and uveitis in childhood].
    Heiligenhaus A; Horneff G; Greiner K; Mackensen F; Zierhut M; Foeldvari I; Michels H
    Klin Monbl Augenheilkd; 2007 Jun; 224(6):526-31. PubMed ID: 17594625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-TNF-α in the treatment of uveitis in the Besançon Hospital].
    Fery-Blanco C; Schwartz C; Gil H; Curlier E; Prati C; Delbosc B
    J Fr Ophtalmol; 2011 Dec; 34(10):697-702. PubMed ID: 21889230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunological laboratory studies in neurological diagnosis].
    Silvennoinen-Kassinen S
    Duodecim; 1986; 102(5):300-5. PubMed ID: 3516641
    [No Abstract]   [Full Text] [Related]  

  • 25. Recent advances in the study of uveitis.
    Perkins ES
    Br J Ophthalmol; 1974 Apr; 58(4):462-7. PubMed ID: 4606986
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.
    Tognon S; Graziani G; Marcolongo R
    Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uveitis and multiple sclerosis in an adolescent.
    Curless RG; Bray PF
    Am J Dis Child; 1972 Feb; 123(2):149-50. PubMed ID: 5025861
    [No Abstract]   [Full Text] [Related]  

  • 28. Possible molecular mechanisms to account for the efficacy of allopurinol against experimental autoimmune uveitis.
    Namazi MR
    Int Immunopharmacol; 2004 Jan; 4(1):161-2. PubMed ID: 14975372
    [No Abstract]   [Full Text] [Related]  

  • 29. Neuro-ophthalmology of multiple sclerosis.
    Eggenberger E
    Curr Opin Ophthalmol; 1996 Dec; 7(6):19-29. PubMed ID: 10166548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate and chronic uveitis associated with juvenile idiopathic arthritis.
    Chan AY; Liu DT
    J Rheumatol; 2006 Jan; 33(1):198; author reply 198. PubMed ID: 16395772
    [No Abstract]   [Full Text] [Related]  

  • 31. Intravitreal infliximab for the treatment of sight-threatening chronic noninfectious uveitis.
    Farvardin M; Afarid M; Mehryar M; Hosseini H
    Retina; 2010 Oct; 30(9):1530-5. PubMed ID: 20924267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunodepressors in ophthalmology].
    Bonnet M
    Annee Ther Clin Ophtalmol; 1971; 22():117-55. PubMed ID: 4356770
    [No Abstract]   [Full Text] [Related]  

  • 33. Infliximab-induced demyelination causes visual disturbance mistaken for recurrence of HLA-B27-related uveitis.
    Papadia M; Herbort CP
    Ocul Immunol Inflamm; 2010 Dec; 18(6):482-4. PubMed ID: 20735341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis.
    Zulian F; Balzarin M; Falcini F; Martini G; Alessio M; Cimaz R; Cimino L; Zannin ME
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):821-5. PubMed ID: 20191477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral MRI is necessary in patients with rheumatoid arthritis and uveitis before undergoing therapy with TNF-alpha blocking agents.
    Limmroth V; Thimm C; Hudde T; Fuchsluger T; Wanke I
    Rheumatology (Oxford); 2005 Nov; 44(11):1373. PubMed ID: 16244102
    [No Abstract]   [Full Text] [Related]  

  • 36. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.
    Saurenmann RK; Levin AV; Rose JB; Parker S; Rabinovitch T; Tyrrell PN; Feldman BM; Laxer RM; Schneider R; Silverman ED
    Rheumatology (Oxford); 2006 Aug; 45(8):982-9. PubMed ID: 16461435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral uveitis in patients with multiple sclerosis.
    Giles CL
    Am J Ophthalmol; 1970 Jul; 70(1):17-9. PubMed ID: 5421649
    [No Abstract]   [Full Text] [Related]  

  • 38. Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors.
    Solomon AJ; Spain RI; Kruer MC; Bourdette D
    Mult Scler; 2011 Dec; 17(12):1472-87. PubMed ID: 21816758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positive and negative implications of tumor necrosis factor neutralization for the pathogenesis of multiple sclerosis.
    Taoufik E; Tseveleki V; Euagelidou M; Emmanouil M; Voulgari-Kokota A; Haralambous S; Probert L
    Neurodegener Dis; 2008; 5(1):32-7. PubMed ID: 18075273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple Sclerosis-Associated Uveitis.
    Cunningham ET; Pavesio CE; Goldstein DA; Forooghian F; Zierhut M
    Ocul Immunol Inflamm; 2017 Jun; 25(3):299-301. PubMed ID: 28696171
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.